GPCRana

GPCRana quantifies residue-residue contact scores (RRCS) to compare conformational states of class A G-protein-coupled receptors (GPCRs) and identify common activation pathways.


Key Features:

  • Quantitative Analysis of GPCR Structures: Quantifies conformational changes across class A GPCRs using a dataset comprising 234 structures from 45 different receptors.
  • Comparison of Residue-Residue Contact Scores (RRCS): Compares RRCS between two GPCR structures to reveal structural variations and their functional implications.
  • Activation Pathway Analysis: Identifies a common activation pathway in class A GPCRs involving 34 residue pairs and 35 residues and integrating motifs CWxP, DRY, Na+ pocket, NPxxY, and PIF to link the ligand-binding pocket to the G-protein coupling region.
  • Ligand-Receptor Interaction Analysis: Examines residue-level ligand-receptor interactions and their effects on receptor activation, including the outward movement of transmembrane helix 6 (TM6).
  • Mechanistic Insights into Activation and Mutations: Provides mechanistic interpretation of constitutively activating, inactivating, and disease-related mutations by analyzing residue contributions to receptor activation.

Scientific Applications:

  • Drug Discovery and Development: Elucidates activation pathways and key residue interactions to aid identification of therapeutic targets within GPCRs.
  • Structural Biology Research: Enables exploration of GPCR structural dynamics and allosteric activation mechanisms.
  • Mutagenesis Studies: Supports design and interpretation of site-directed mutagenesis experiments by predicting how mutations in specific residues affect receptor activity.

Methodology:

GPCRana quantifies conformational changes by comparing residue-residue contact scores (RRCS) across GPCR structures and integrates these comparisons from extensive structural analyses to derive a unified activation mechanism.

Topics

Collections

Details

Tool Type:
web application
Added:
7/25/2023
Last Updated:
11/24/2024

Operations

Publications

Zhou Q, Yang D, Wu M, Guo Y, Guo W, Zhong L, Cai X, Dai A, Jang W, Shakhnovich EI, Liu Z, Stevens RC, Lambert NA, Babu MM, Wang M, Zhao S. Common activation mechanism of class A GPCRs. eLife. 2019;8. doi:10.7554/elife.50279. PMID:31855179. PMCID:PMC6954041.

PMID: 31855179
PMCID: PMC6954041
Funding: - Medical Research Council: MC_U105185859 - Novo Nordisk-CAS Research: NNCAS-2017-1-CC - Shanghai Science and Technology Development Fund: 16ZR1407100, 16ZR1448500 - National Natural Science Foundation of China: 21704064, 31971178, 81573479, 81773792, 81872915 - National Mega R&D Program for Drug Discovery: 2018ZX09711002-002-005, 2018ZX09735-001 - National Key R&D Program of China: 2016YFC0905900, 2018YFA0507000 - National Institute of General Medical Sciences: GM130142